Cargando…

Deep Learning Plus Three-Dimensional Printing in the Management of Giant (>15 cm) Sporadic Renal Angiomyolipoma: An Initial Report

OBJECTIVE: To evaluate the feasibility and effectivity of deep learning (DL) plus three-dimensional (3D) printing in the management of giant sporadic renal angiomyolipoma (RAML). METHODS: The medical records of patients with giant (>15 cm) RAML were retrospectively reviewed from January 2011 to D...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yunliang, Tang, Yuanyuan, Ren, Da, Cheng, Shunhua, Wang, Yinhuai, Yi, Lu, Peng, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634108/
https://www.ncbi.nlm.nih.gov/pubmed/34868918
http://dx.doi.org/10.3389/fonc.2021.724986
_version_ 1784608070704300032
author Gao, Yunliang
Tang, Yuanyuan
Ren, Da
Cheng, Shunhua
Wang, Yinhuai
Yi, Lu
Peng, Shuang
author_facet Gao, Yunliang
Tang, Yuanyuan
Ren, Da
Cheng, Shunhua
Wang, Yinhuai
Yi, Lu
Peng, Shuang
author_sort Gao, Yunliang
collection PubMed
description OBJECTIVE: To evaluate the feasibility and effectivity of deep learning (DL) plus three-dimensional (3D) printing in the management of giant sporadic renal angiomyolipoma (RAML). METHODS: The medical records of patients with giant (>15 cm) RAML were retrospectively reviewed from January 2011 to December 2020. 3D visualized and printed kidney models were performed by DL algorithms and 3D printing technology, respectively. Patient demographics and intra- and postoperative outcomes were compared between those with 3D-assisted surgery (3D group) or routine ones (control group). RESULTS: Among 372 sporadic RAML patients, 31 with giant ones were eligible for analysis. The median age was 40.6 (18–70) years old, and the median tumor size was 18.2 (15–28) cm. Seventeen of 31 (54.8%) had a surgical kidney removal. Overall, 11 underwent 3D-assisted surgeries and 20 underwent routine ones. A significant higher success rate of partial nephrectomy (PN) was noted in the 3D group (72.7% vs. 30.0%). Patients in the 3D group presented a lower reduction in renal function but experienced a longer operation time, a greater estimated blood loss, and a higher postoperative morbidity. Subgroup analysis was conducted between patients undergoing PN with or without 3D assistance. Despite no significant difference, patients with 3D-assisted PN had a slightly larger tumor size and higher nephrectomy score, possibly contributing to a relatively higher rate of complications. However, 3D-assisted PN lead to a shorter warm ischemia time and a lower renal function loss without significant difference. Another subgroup analysis between patients under 3D-assisted PN or 3D-assisted RN showed no statistically significant difference. However, the nearness of tumor to the second branch of renal artery was relatively shorter in 3D-assisted PN subgroup than that in 3D-assisted RN subgroup, and the difference between them was close to significant. CONCLUSIONS: 3D visualized and printed kidney models appear to be additional tools to assist operational management and avoid a high rate of kidney removal for giant sporadic RAMLs.
format Online
Article
Text
id pubmed-8634108
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86341082021-12-02 Deep Learning Plus Three-Dimensional Printing in the Management of Giant (>15 cm) Sporadic Renal Angiomyolipoma: An Initial Report Gao, Yunliang Tang, Yuanyuan Ren, Da Cheng, Shunhua Wang, Yinhuai Yi, Lu Peng, Shuang Front Oncol Oncology OBJECTIVE: To evaluate the feasibility and effectivity of deep learning (DL) plus three-dimensional (3D) printing in the management of giant sporadic renal angiomyolipoma (RAML). METHODS: The medical records of patients with giant (>15 cm) RAML were retrospectively reviewed from January 2011 to December 2020. 3D visualized and printed kidney models were performed by DL algorithms and 3D printing technology, respectively. Patient demographics and intra- and postoperative outcomes were compared between those with 3D-assisted surgery (3D group) or routine ones (control group). RESULTS: Among 372 sporadic RAML patients, 31 with giant ones were eligible for analysis. The median age was 40.6 (18–70) years old, and the median tumor size was 18.2 (15–28) cm. Seventeen of 31 (54.8%) had a surgical kidney removal. Overall, 11 underwent 3D-assisted surgeries and 20 underwent routine ones. A significant higher success rate of partial nephrectomy (PN) was noted in the 3D group (72.7% vs. 30.0%). Patients in the 3D group presented a lower reduction in renal function but experienced a longer operation time, a greater estimated blood loss, and a higher postoperative morbidity. Subgroup analysis was conducted between patients undergoing PN with or without 3D assistance. Despite no significant difference, patients with 3D-assisted PN had a slightly larger tumor size and higher nephrectomy score, possibly contributing to a relatively higher rate of complications. However, 3D-assisted PN lead to a shorter warm ischemia time and a lower renal function loss without significant difference. Another subgroup analysis between patients under 3D-assisted PN or 3D-assisted RN showed no statistically significant difference. However, the nearness of tumor to the second branch of renal artery was relatively shorter in 3D-assisted PN subgroup than that in 3D-assisted RN subgroup, and the difference between them was close to significant. CONCLUSIONS: 3D visualized and printed kidney models appear to be additional tools to assist operational management and avoid a high rate of kidney removal for giant sporadic RAMLs. Frontiers Media S.A. 2021-11-15 /pmc/articles/PMC8634108/ /pubmed/34868918 http://dx.doi.org/10.3389/fonc.2021.724986 Text en Copyright © 2021 Gao, Tang, Ren, Cheng, Wang, Yi and Peng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Gao, Yunliang
Tang, Yuanyuan
Ren, Da
Cheng, Shunhua
Wang, Yinhuai
Yi, Lu
Peng, Shuang
Deep Learning Plus Three-Dimensional Printing in the Management of Giant (>15 cm) Sporadic Renal Angiomyolipoma: An Initial Report
title Deep Learning Plus Three-Dimensional Printing in the Management of Giant (>15 cm) Sporadic Renal Angiomyolipoma: An Initial Report
title_full Deep Learning Plus Three-Dimensional Printing in the Management of Giant (>15 cm) Sporadic Renal Angiomyolipoma: An Initial Report
title_fullStr Deep Learning Plus Three-Dimensional Printing in the Management of Giant (>15 cm) Sporadic Renal Angiomyolipoma: An Initial Report
title_full_unstemmed Deep Learning Plus Three-Dimensional Printing in the Management of Giant (>15 cm) Sporadic Renal Angiomyolipoma: An Initial Report
title_short Deep Learning Plus Three-Dimensional Printing in the Management of Giant (>15 cm) Sporadic Renal Angiomyolipoma: An Initial Report
title_sort deep learning plus three-dimensional printing in the management of giant (>15 cm) sporadic renal angiomyolipoma: an initial report
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634108/
https://www.ncbi.nlm.nih.gov/pubmed/34868918
http://dx.doi.org/10.3389/fonc.2021.724986
work_keys_str_mv AT gaoyunliang deeplearningplusthreedimensionalprintinginthemanagementofgiant15cmsporadicrenalangiomyolipomaaninitialreport
AT tangyuanyuan deeplearningplusthreedimensionalprintinginthemanagementofgiant15cmsporadicrenalangiomyolipomaaninitialreport
AT renda deeplearningplusthreedimensionalprintinginthemanagementofgiant15cmsporadicrenalangiomyolipomaaninitialreport
AT chengshunhua deeplearningplusthreedimensionalprintinginthemanagementofgiant15cmsporadicrenalangiomyolipomaaninitialreport
AT wangyinhuai deeplearningplusthreedimensionalprintinginthemanagementofgiant15cmsporadicrenalangiomyolipomaaninitialreport
AT yilu deeplearningplusthreedimensionalprintinginthemanagementofgiant15cmsporadicrenalangiomyolipomaaninitialreport
AT pengshuang deeplearningplusthreedimensionalprintinginthemanagementofgiant15cmsporadicrenalangiomyolipomaaninitialreport